Newsletter Subject

AMA: What's Going On With The Market?

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Fri, Apr 3, 2020 04:59 PM

Email Preheader Text

 I Didn’t Do It By Shorting Stocks Instead I Tapped Into A Hidden Bull Market  I’ve Ne

[Image] The Dow Just Had Its Worst First Quarter ever Meanwhile, I managed To Wrestle Down $477K In Trading Profits  [Image](  I Didn’t Do It By Shorting Stocks Instead I Tapped Into A Hidden Bull Market  I’ve Never Made So Much Money... So Fast And Now I Want To Help You Unlock It Too [Watch Now]( Hello Undefined,  As we enter a new quarter… traders are scrambling to put the pieces of the puzzle together to generate alpha in this environment. For the most part, Q2 2020 has been [pure chaos]( — as the coronavirus pandemic continues to damage the global economy. I take pride in being known as The People’s Trader around here… so I opened up a discussion with my readers, and since it’s been a tough time for many of you out there… [I want to try my best to help as many people out as possible.]( As I looked through all the responses with my team, I found one common question: [what’s going on with the market?]( Well, at one point, the S&P 500 (SPY) was down 35% from its high… and the velocity of the move was unprecedented. If you just take a look at the heatmap for stocks (for Q1 2020), from Finviz, you can see there are very few stocks that were up.  [Image](  Today, I want to walk you through exactly what’s going on in the market… but more importantly, [how it directly affects you.]( Not only that, but I want to show you how I tapped into a [hidden bull market.]( Of course, if you’re an investor… It's been a tough environment. However,If you’re a trader like myself, this is an exciting environment. [The moves I’m witnessing are anomalies, and there are plenty of opportunities to take advantage of.Â]( Even though the market has been decimated, there have been pockets in the market that have been quietly skyrocketing… which is exactly how I’ve locked in more than $477K in March alone!  [Image](  How have I been able to do that… and what the heck is going on with this market? [Click here to continue reading...](  [Image] Kyle Dennis The People's Trader     [Click here to unsubscribe and stop receiving exclusive emails from kyle@biotechbreakouts.com]( Neither Kyle Dennis nor RagingBull.com, LLC (publisher of BiotechBreakouts) is registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. The owners, employees and writers of RagingBull.com may engage in securities trading that is discussed or viewed on this website, but all such individuals are buying and selling such securities for their own account. These individuals do not engage in any trades with customers. The buying and selling of securities by these individuals is not part of a regular business of buying and selling securities. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for RagingBull.com, LLC may have long or short positions in securities that may be discussed on this website or newsletter, but all such positions are held for such representative’s own account. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are actual figures from the portfolios Kyle Dennis manages on behalf of RagingBull.com, LLC. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.   [Unsubscribe from all RagingBull Emails]( 62 Calef Hwy #233 Lee, New Hampshire 03861 United States

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.